Coptisine sulfate

CAS No. 1198398-71-8

Coptisine sulfate( —— )

Catalog No. M17873 CAS No. 1198398-71-8

Coptisine sulfate has growth inhibitory activity against human cancer cell line in the NCI's anticancer drug screening program.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 In Stock
10MG 75 In Stock
25MG 163 In Stock
50MG 240 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Coptisine sulfate
  • Note
    Research use only, not for human use.
  • Brief Description
    Coptisine sulfate has growth inhibitory activity against human cancer cell line in the NCI's anticancer drug screening program.
  • Description
    Coptisine sulfate has growth inhibitory activity against human cancer cell line in the NCI's anticancer drug screening program.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1198398-71-8
  • Formula Weight
    320.32
  • Molecular Formula
    C19H14NO4+
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 1 mg/mL (2.40 mM)
  • SMILES
    C1C[N+]2=C(C=C3C=CC4=C(C3=C2)OCO4)C5=CC6=C(C=C51)OCO6
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Mirogabalin

    Mirogabalin (DS-5565) is a novel potent, selective ligand of the α2δ subunit of voltage-gated calcium channels with Kd of 13.5/22.7/27.0/47.6 nM for huamn α2δ-1, human α2δ-2, rat α2δ-1 and rat α2δ-2 subunits, respectively.

  • Ziconotide

    Ziconotide is an atypical analgesic agent for the amelioration of severe and chronic pain. Derived from Conus magus, a cone snail, it is the synthetic form of an ω-conotoxin peptide.

  • TROX-1

    A potent, state-dependent blocker of Cav2 channels that preferentially inhibits potassium-triggered calcium influx through recombinant Cav2.2 under depolarized conditions with IC50 of 0.27 uM.